Iria Vázquez

1.6k total citations
24 papers, 782 citations indexed

About

Iria Vázquez is a scholar working on Molecular Biology, Hematology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Iria Vázquez has authored 24 papers receiving a total of 782 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 14 papers in Hematology and 5 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Iria Vázquez's work include Acute Myeloid Leukemia Research (12 papers), Acute Lymphoblastic Leukemia research (5 papers) and Epigenetics and DNA Methylation (4 papers). Iria Vázquez is often cited by papers focused on Acute Myeloid Leukemia Research (12 papers), Acute Lymphoblastic Leukemia research (5 papers) and Epigenetics and DNA Methylation (4 papers). Iria Vázquez collaborates with scholars based in Spain, Belgium and Italy. Iria Vázquez's co-authors include Anna Sablina, Marı́a José Calasanz, Layka Abbasi Asbagh, Peter Kalev, Xabier Agirre, María D. Odero, Idoya Lahortiga, Felipe Prósper, María José Larráyoz and José Román‐Gómez and has published in prestigious journals such as Blood, PLoS ONE and Cancer Cell.

In The Last Decade

Iria Vázquez

23 papers receiving 774 citations

Peers

Iria Vázquez
Archana Agarwal United States
Jennifer Cain United States
Jonathan Walsh United States
Chung Hoow Kok Australia
Iria Vázquez
Citations per year, relative to Iria Vázquez Iria Vázquez (= 1×) peers Šárka Pavlová

Countries citing papers authored by Iria Vázquez

Since Specialization
Citations

This map shows the geographic impact of Iria Vázquez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iria Vázquez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iria Vázquez more than expected).

Fields of papers citing papers by Iria Vázquez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iria Vázquez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iria Vázquez. The network helps show where Iria Vázquez may publish in the future.

Co-authorship network of co-authors of Iria Vázquez

This figure shows the co-authorship network connecting the top 25 collaborators of Iria Vázquez. A scholar is included among the top collaborators of Iria Vázquez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Iria Vázquez. Iria Vázquez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Vázquez, Iria, María José Larráyoz, Ramón García‐Sánz, et al.. (2020). Assessment of the clinical utility of four NGS panels in myeloid malignancies. Suggestions for NGS panel choice or design. PLoS ONE. 15(1). e0227986–e0227986. 30 indexed citations
3.
Larráyoz, María José, Iria Vázquez, Teresa Bernal, et al.. (2020). Strategy for identification of a potential inherited leukemia predisposition in a 299 patient’s cohort with tumor-only sequencing data. Leukemia Research. 95. 106386–106386. 2 indexed citations
4.
Viguria, María C., Isabel Zudaire, Felipe Prósper, et al.. (2020). Assessment of Minimal Residual Disease by Next Generation Sequencing in Peripheral Blood as a Complementary Tool for Personalized Transplant Monitoring in Myeloid Neoplasms. Journal of Clinical Medicine. 9(12). 3818–3818. 11 indexed citations
5.
Maicas, Miren, Iria Vázquez, Rafael Alis, et al.. (2017). The MDS and EVI1 complex locus (MECOM) isoforms regulate their own transcription and have different roles in the transformation of hematopoietic stem and progenitor cells. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms. 1860(6). 721–729. 15 indexed citations
6.
Cai, Yanyan, Tibor J. Pastor, Layka Abbasi Asbagh, et al.. (2016). Loss of Chromosome 8p Governs Tumor Progression and Drug Response by Altering Lipid Metabolism. Cancer Cell. 29(5). 751–766. 126 indexed citations
7.
Dok, Rüveyda, Peter Kalev, Evert J. Van Limbergen, et al.. (2014). p16INK4a Impairs Homologous Recombination–Mediated DNA Repair in Human Papillomavirus–Positive Head and Neck Tumors. Cancer Research. 74(6). 1739–1751. 99 indexed citations
8.
Kalev, Peter, Michal Šimíček, Iria Vázquez, et al.. (2012). Loss of PPP2R2A Inhibits Homologous Recombination DNA Repair and Predicts Tumor Sensitivity to PARP Inhibition. Cancer Research. 72(24). 6414–6424. 103 indexed citations
9.
Maicas, Miren, Iria Vázquez, Carmen Vicente, et al.. (2012). Functional characterization of the promoter region of the human EVI1 gene in acute myeloid leukemia: RUNX1 and ELK1 directly regulate its transcription. Oncogene. 32(16). 2069–2078. 22 indexed citations
10.
Vázquez, Iria, Miren Maicas, Javier Lizardi Cervera, et al.. (2011). Down-regulation of EVI1 is associated with epigenetic alterations and good prognosis in patients with acute myeloid leukemia. Haematologica. 96(10). 1448–1456. 42 indexed citations
11.
Gómez‐Benito, María José, Ana Conchillo, Miguel A. Garcı́a, et al.. (2010). EVI1 controls proliferation in acute myeloid leukaemia through modulation of miR-1-2. British Journal of Cancer. 103(8). 1292–1296. 31 indexed citations
12.
José‐Eneriz, Edurne San, Xabier Agirre, José Román‐Gómez, et al.. (2006). Downregulation of DBC1 expression in acute lymphoblastic leukaemia is mediated by aberrant methylation of its promoter. British Journal of Haematology. 134(2). 137–144. 25 indexed citations
13.
Agirre, Xabier, José Román‐Gómez, Iria Vázquez, et al.. (2005). Coexistence of different clonal populations harboring the b3a2 (p210) and e1a2 (p190) BCR-ABL1 fusion transcripts in chronic myelogenous leukemia resistant to imatinib. Cancer Genetics and Cytogenetics. 160(1). 22–26. 10 indexed citations
14.
Agirre, Xabier, José Román‐Gómez, Iria Vázquez, et al.. (2005). Abnormal methylation of the common PARK2 and PACRG promoter is associated with downregulation of gene expression in acute lymphoblastic leukemia and chronic myeloid leukemia. International Journal of Cancer. 118(8). 1945–1953. 76 indexed citations
15.
Agirre, Xabier, José Román‐Gómez, Antonio Jiménez‐Velasco, et al.. (2005). ASPP1, a common activator of TP53, is inactivated by aberrant methylation of its promoter in acute lymphoblastic leukemia. Oncogene. 25(13). 1862–1870. 56 indexed citations
16.
Lahortiga, Idoya, Elena Belloni, Iria Vázquez, et al.. (2005). NUP98 is fused to HOXA9 in a variant complex t(7;11;13;17) in a patient with AML-M2. Cancer Genetics and Cytogenetics. 157(2). 151–156. 4 indexed citations
19.
Lahortiga, Idoya, Iria Vázquez, Xabier Agirre, et al.. (2004). Molecular heterogeneity in AML/MDS patients with 3q21q26 rearrangements. Genes Chromosomes and Cancer. 40(3). 179–189. 35 indexed citations
20.
Lahortiga, Idoya, J.L. Vizmanos, Xabier Agirre, et al.. (2003). NUP98 is fused to adducin 3 in a patient with T-cell acute lymphoblastic leukemia and myeloid markers, with a new translocation t(10;11)(q25;p15).. PubMed. 63(12). 3079–83. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026